Incyte Corporation http://www.alacrastore.com/company-snapshot/Incyte_Corporation-1077514 Saturday, August 30, 2008 12:09:07 AM 1077514 Incyte Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/BW-0001-27217440newstex/BW-0001-27217440xml Aug. #, #### (Business Wire) -- Incyte Corporation (Nasdaq:INCY) today announced the closing of its public offering of ##,###,### shares of its common stock at a price to the public of $#.## per share, which includes #,###,### shares...0400000004016000040160198/6/2008 5:22:12 PM1800000018013000190000001900100019001032Business WireBW-0001-27217440GOLDMAN SACHS GROUP INCINCYTE CORPMORGAN STANLEYGSINCYMSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-27083335newstex/BW-0001-27083335xml Jul. ##, #### (Business Wire) -- Incyte Corporation (Nasdaq:INCY) today announced the pricing of its underwritten public offering of ##,###,### shares of its common stock at a price to the public of $#.## per share. The size of the...0400000004016000040160197/31/2008 7:17:40 PM1800000018013000190000001900100019001032Business WireBW-0001-27083335GOLDMAN SACHS GROUP INCINCYTE CORPMORGAN STANLEYGSINCYMSNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1907783ccbn/T1907783norm...Greetings, ladies and gentlemen, and welcome to the Incyte Corporation's second-quarter #### financial results. At this time, all participants are in a listen-only mode and a brief question-and-answer session will follow the formal presentation. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Pamela Murphy, VP of Investor Relations and Communications. Thank you. Ms. Murphy, you may now begin. ... 7/30/2008 11:06:00 AMIncyte Corporation54.0000FinalIncyte Corporation Q2 2008 Earnings Conference Call TranscriptINCY8:00am ETTranscriptT1907783Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1907783ccbn/B1907783norm...Rapidly improved quality of life measures including clinically meaningful reductions in fatigue night sweats and pruritus. ... 7/30/2008 10:06:00 AMIncyte Corporation54.0000EditedIncyte Corporation Q2 2008 Earnings Conference Call SummaryINCY8:00am ETBriefB1907783Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-27012204newstex/BW-0001-27012204xml Jul. ##, #### (Business Wire) -- Incyte Corporation (Nasdaq:INCY) today announced its second quarter #### financial results and reported continued progress in several lead clinical programs. Paul Friedman, M.D., President and CEO...07000000070050000400000004002000040020060401600004016048040160180401600104016052070140000701400607014014070140080701400107014017070010000700100402000000020020000200200402002005020020071300000013001000130010027/29/2008 5:17:32 PM18000000180080001802200019000000190010001900200019002007Business WireBW-0001-27012204INCYTE CORPPAUL A FRIEDMANINCYNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-27012254newstex/BW-0001-27012254xml Jul. ##, #### (Business Wire) -- Incyte Corporation (Nasdaq:INCY) today announced that it intends to offer to sell, subject to market and other conditions, #,###,### shares of its common stock in an underwritten public offering. In...0400000004016000040160197/29/2008 5:17:32 PM1800000018013000190000001900100019001032Business WireBW-0001-27012254GOLDMAN SACHS GROUP INCINCYTE CORPMORGAN STANLEYGSINCYMSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-26845344newstex/BW-0001-26845344xml Jul. ##, #### (Business Wire) -- Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter #### financial results conference call for #:## a.m. ET on Thursday, July ##, ####. The schedules for the press...040000000401600004016048040160187/22/2008 6:16:49 PM180000001800400018008000Business WireBW-0001-26845344INCYTE CORPINCYNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1874532ccbn/B1874532norm...Co. reported initial safety and efficacy data on INCB######, a selective JAK# and JAK# in RA. INCB###### at ## mg BID was safe and well tolerated in RA patients with active disease. ... 6/12/2008 12:04:00 PMIncyte Corporation54.0000Editeds EULAR 2008 Conference Call SummaryINCY8:30am ETBriefB1874532Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1828629ccbn/B1828629norm...Co. reported that it has eight active Phase II trials. Co. believes it remains well positioned financially to focus resources on high-value programs moving through #### and beyond. ... 4/30/2008 2:05:00 PMIncyte Corporation54.0000EditedQ1 2008 Incyte Corporation Earnings Conference Call SummaryINCY8:30am ETBriefB1828629Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1828629ccbn/T1828629norm...Greetings, ladies and gentlemen, and welcome to the Incyte Corporation first-quarter #### financial results. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Pamela Murphy, VP of Investor Relations. Thank you. Ms. Murphy, you may now begin. ... 4/30/2008 11:05:00 AMIncyte Corporation54.0000FinalQ1 2008 Incyte Corporation Earnings Conference Call TranscriptINCY8:30am ETTranscriptT1828629Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/bir/265672bir/265672normIncyte Corp.Combion Inc.Incyte Pharmaceuticals Inc.Genome Systems Inc.Proteome Inc.Incyte Genomics Inc.United StatesServices: Biotechnology, drug discovery and development.873154171017CFINCY3/5/2008 6:50:00 AM265672Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/B1759677ccbn/B1759677normQ# #### Incyte Corporation Earnings Conference Call2/14/2008 10:06:00 AMIncyte Corporation106.0000EditedQ4 2007 Incyte Corporation Earnings Conference Call SummaryINCY8:30am ETBriefB1759677Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1759677ccbn/T1759677normQ# #### Incyte Corporation Earnings Conference Call2/14/2008 10:06:00 AMIncyte Corporation106.0000FinalQ4 2007 Incyte Corporation Earnings Conference Call TranscriptINCY8:30am ETTranscriptT1759677Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1666923ccbn/B1666923norm11/1/2007 12:07:00 PMIncyte Corporation54.0000EditedQ3 2007 Incyte Corporation Earnings Conference Call SummaryINCY8:30am ET...Has demonstrated clinical proof-of-concept in four of Co.'s wholly owned, internally developed programs. ... BriefB1666923Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1666923ccbn/T1666923norm11/1/2007 11:06:00 AMIncyte Corporation54.0000FinalQ3 2007 Incyte Corporation Earnings Conference Call TranscriptINCY8:30am ET...Greetings, ladies and gentlemen and welcome to the Incyte Corporation third-quarter #### financial results call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Pamela Murphy, VP Investor Relations and Communications for Incyte Corporation. Thank you, Ms. Murphy. You may begin. ... TranscriptT1666923Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/22945srp/22945norm...Address:Experimental Station, Route ### & Henry Clay Road, Building E###, Wilmington, Delaware ##### Incorporated:DelawareWeb Site: www.incyte.comSIC Classification: Commercial Physical and Biological Research (####) Business Description: Incyte Corporation is a leader in genomics-advantaged therapeutic discovery and development. The company has the largest commercial portfolio of issued United States patents covering human, full-length genes and the proteins they encode. The company is leveraging its leading intellectual property and genomic information position to be a leader in discovering and developing therapeutic small molecules, secreted proteins and antibodies. In addition, the company has developed the leading integrated platform of genomic technologies designed to aid in the understanding of the molecular basis of disease. The company develops and markets genomic databases and licenses pharmaceutically relevant intellectual property. Indices:Russell ####, Russell #### ... 2294545337C102INCY10/6/2006 12:23:00 PM22945Credit & Investment ResearchSharkRepellent.net